# Clinical Study on Adoptive Treatment of MDR-TB With Allogeneic γδT Cells

> **NCT03575299** · PHASE1 · UNKNOWN · sponsor: **Zhinan Yin, Ph.D.** · enrollment: 45 (estimated)

## Conditions studied

- Multi-drug Resistant Tuberculosis

## Interventions

- **BIOLOGICAL:** The adoptive treatment of allogeneic γδT cells
- **OTHER:** Control
- **DRUG:** Conventional treatment

## Key facts

- **NCT ID:** NCT03575299
- **Lead sponsor:** Zhinan Yin, Ph.D.
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-06-01
- **Primary completion:** 2021-06-30
- **Final completion:** 2021-12-31
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2018-07-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03575299

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03575299, "Clinical Study on Adoptive Treatment of MDR-TB With Allogeneic γδT Cells". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03575299. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*